CDMRP Ovarian Cancer Clinical Translational Research Award

0
238

Funding Opportunity ID:331382
Opportunity Number:W81XWH-21-OCRP-CTRA
Opportunity Title:CDMRP Ovarian Cancer Clinical Translational Research Award
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Cooperative Agreement
Grant
Category of Funding Activity:Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s):12.420
Eligible Applicants:Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code:DOD-AMRAA
Agency Name:Department of Defense
Dept. of the Army — USAMRAA
Posted Date:Feb 08, 2021
Close Date:Jul 08, 2021
Last Updated Date:Feb 08, 2021
Award Ceiling:$0
Award Floor:$0
Estimated Total Program Funding:$2,880,000
Expected Number of Awards:4
Description:The Clinical Translational Research Award is intended to support correlative studies that are associated with a clinical trial. The translational research should address high-impact or unmet needs in ovarian cancer. Applications focused on the following OCRP priority are encouraged to apply:* Utilize precision medicine and computational approaches that identify individual tumor characteristics and predictive biomarkers across diverse groups to optimize patient care and outcomesAlthough not intended to fund the operational aspects of clinical trials, this award supports research projects related to or associated with planned, ongoing, or completed clinical trials supported by other funding sources. Projects that develop clinical endpoints for clinical trials are also encouraged. The application must demonstrate availability and accessibility of the appropriate human subject population, specimens, or human-based resources. The application should also provide a detailed statistical analysis plan that includes a power analysis reflecting sample size projections that will allow a meaningful outcome. Preclinical studies in animals are not allowed.
Version:1





Visit the Official Webpage For More Details on CDMRP Ovarian Cancer Clinical Translational Research Award

LEAVE A REPLY

Please enter your comment!
Please enter your name here